Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing

YEN-TING LINChiang, Chi-LuChi-LuChiangHung, Jen-YuJen-YuHungLee, Mei-HsuanMei-HsuanLeeSu, Wu-ChouWu-ChouSuWu, Shang-YinShang-YinWuWei, Yu-FengYu-FengWeiLee, Kang-YunKang-YunLeeTseng, Yen-HanYen-HanTsengSu, JianJianSuChung, Hsin-PeiHsin-PeiChungLin, Chih-BinChih-BinLinKu, Wen-HuiWen-HuiKuChiang, Tsai-ShinTsai-ShinChiangChiu, Chao-HuaChao-HuaChiuJIN-YUAN SHIH2021-11-032021-11-0320210959-8049https://www.scopus.com/inward/record.uri?eid=2-s2.0-85112384251&doi=10.1016%2fj.ejca.2021.06.043&partnerID=40&md5=fd1c105dd5aed7d740a2909685a1bdc1https://scholars.lib.ntu.edu.tw/handle/123456789/586128[SDGs]SDG3Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencingjournal article10.1016/j.ejca.2021.06.043343921862-s2.0-85112384251